Clinical Trials

Showing trials with last updates posted in 2016.

NCT02281279 | WITHDRAWN | PHASE1/PHASE2
0 participants

Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2016-08-11
Start Date:
2016-10-31
Completion:
2020-10-31
Conditions
  • B-cell Adult Acute Lymphoblastic Leukemia
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • Intraocular Lymphoma
  • Nodal Marginal Zone B-cell Lymphoma
  • Recurrent Adult Acute Lymphoblastic Leukemia
  • Recurrent Adult Burkitt Lymphoma
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Recurrent Adult Diffuse Mixed Cell Lymphoma
  • Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
  • Recurrent Adult Grade III Lymphomatoid Granulomatosis
  • Recurrent Adult Immunoblastic Large Cell Lymphoma
  • Recurrent Adult Lymphoblastic Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3 Follicular Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Small Lymphocytic Lymphoma
  • Refractory Hairy Cell Leukemia
  • Small Intestine Lymphoma
  • Splenic Marginal Zone Lymphoma
  • Testicular Lymphoma
  • Waldenström Macroglobulinemia
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
No Results Yet
NCT02023528 | COMPLETED
243 participants

Dialysis Registry in Utah

Study Type:
OBSERVATIONAL
Last Updated:
2016-08-11
Start Date:
2008-01-31
Completion:
2015-12-31
Conditions
  • Hemodialysis
No Results Yet
NCT01500070 | COMPLETED | PHASE2
70 participants

PREVENT: Promus BTK

Study Type:
INTERVENTIONAL
Last Updated:
2016-08-11
Start Date:
2012-08-31
Completion:
2016-01-31
Conditions
  • Peripheral Arterial Disease
Interventions
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page